Tramadol Hydrochloride Tablet, Coated
Product Images NDC 0904-7496

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 0904-7496). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50mg Carton Label (6b0b95b2 Ae4c 42e8 9f2e Bcdaffda62e2 00)

50mg Carton Label (6b0b95b2 Ae4c 42e8 9f2e Bcdaffda62e2 00)
Tramadol Hydrochloride 50 mg coated tablets by Major Pharmaceuticals. The label indicates a unit dose package containing 100 tablets (10 x 10). It includes dosing and storage instructions, a strong warning to keep out of children’s reach, and notes the product is for institutional use only. The label displays the National Drug Code (NDC) 0904-7496-61 and states the tablets are prescription only.*
FDA Label Image

1 (Tramadol Hydrochloride Tablets Usp 50 mg 1)

1 (Tramadol Hydrochloride Tablets Usp 50 mg 1)
Chemical structure of Tramadol Hydrochloride, showing its molecular components including the methoxyphenyl group, cyclohexanol ring, dimethylamino methyl side chain, and the hydrochloride component.*
FDA Label Image

1 (Tramadol Hydrochloride Tablets Usp 50 mg 2)

1 (Tramadol Hydrochloride Tablets Usp 50 mg 2)
A concentration-time graph showing plasma levels of Tramadol and its metabolite M1 over 48 hours. The graph compares multiple dose and single dose profiles for both Tramadol and M1, with concentration (ng/mL) on the y-axis and time (hours) on the x-axis.*
FDA Label Image

1 (Tramadol Hydrochloride Tablets Usp 50 mg 3)

1 (Tramadol Hydrochloride Tablets Usp 50 mg 3)
A line graph titled 'Protocol CAPSS-047 Time to Discontinuation Due to Nausea/Vomiting' showing percent discontinuing over days in double-blind study. Two lines represent time to reach 200 mg/day: one for 10 days and one for 16 days. The 10-day line shows a higher percent discontinuing compared to the 16-day line across approximately 25 days.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.